Delayed bleeding after implant surgery in patients taking novel oral anticoagulants: a case report
김치헌, 담주겸, 정지은, 곽은정, 박원서,
소속 상세정보
김치헌 ( Kim Chi-Hun ) - Yonsei University Department of Advanced General Dentistry
담주겸 ( Dam Chu-Geum ) - Yonsei University Department of Advanced General Dentistry
정지은 ( Jeong Ji-Eun ) - Yonsei University Department of Advanced General Dentistry
곽은정 ( Kwak Eun-Jung ) - Yonsei University Department of Advanced General Dentistry
박원서 ( Park Won-Se ) - Yonsei University Department of Advanced General Dentistry
KMID : 0980320170170020143
Abstract
The use of novel oral anticoagulants (NOACs) has increased in recent times in an effort to overcome the shortcomings of warfarin. They are being used primarily for the prevention of thrombosis caused by atrial fibrillation and offer the advantages of having fewer drug interactions than warfarin, no dietary restrictions, and no requirement for regular blood tests. Although there is reportedly less postoperative bleeding even if the drug is not discontinued during procedures that can cause local bleeding, such as dental procedures, no well-designed clinical studies have assessed postoperative bleeding associated with the use of these drugs. This article reports a case of a 74-year-old male patient who was taking rivaroxaban. The patient underwent a dental implant procedure after discontinuing rivaroxaban for one day and subsequently suffered delayed bleeding on postoperative day 6. Accordingly, this article also reports that the use of NOACs may also lead to delayed bleeding.
키워드
Anticoagulants; Bleeding; Dental Implants; Emergencies; Rivaroxaban
원문 및 링크아웃 정보
등재저널 정보